Patents Assigned to Purdue Phamaceutical Products L.P.
  • COMPOUNDS FOR TREATING BRAIN CANCER
    Publication number: 20170189382
    Abstract: There is provided a compound of formula I or a pharmacologically acceptable salt thereof: for use in the treatment of a brain cancer selected from a MGMT positive astrocytic brain tumor, a metastatic brain cancer and primary CNS lymphoma and a method of treating said brain cancers in a patient in need thereof comprising administering to the patient said compound of formula I or a pharmacologically acceptable salt thereof.
    Type: Application
    Filed: March 26, 2015
    Publication date: July 6, 2017
    Applicant: Purdue Phamaceutical Products L.P.
    Inventors: Thomas Mehrling, Claudio Festuccia